Survival analysis demonstrates that elevated METTL1 correlates with poor patient prognosis, and both univariate and multivariate Cox regression analyses suggest that METTL1 serves as an independent prognostic risk factor in glioma (48). This evidence concerns the gene METTL1 and glioma.